castanospermine has been researched along with Breast Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Noda, N; Ozawa, T | 1 |
| Ahidouch, A; Allan, G; Fernandez, JM; Ortiz-Mellet, C; Ouadid-Ahidouch, H; Risquez-Cuadro, R; Sanchez-Fernandez, EM | 1 |
2 other study(ies) available for castanospermine and Breast Neoplasms
| Article | Year |
|---|---|
Castanospermine suppresses CD44 ectodomain cleavage as revealed by transmembrane bioluminescent sensors.
Topics: Breast Neoplasms; Cell Movement; Female; Humans; Hyaluronan Receptors; Indolizines | 2022 |
New castanospermine glycoside analogues inhibit breast cancer cell proliferation and induce apoptosis without affecting normal cells.
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Cycle Checkpoints; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Cell Survival; Female; Gene Expression Regulation, Neoplastic; Humans; Indolizines | 2013 |